Oppenheimer analyst Francois Brisebois initiated coverage of Dyne Therapeutics with an Outperform rating and $34 price target.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on DYN:
Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
